Hemangioendothelioma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Clinical Trials

Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects With Advanced Solid Tumors
Conditions:   Solid Tumors, Adult;   Solid Tumor;   Mesothelioma (MPM);   Epithelioid Hemangioendothelioma (EHE);   NF2 Deficient Mesothelioma;   Other NF2 Deficient Solid Tumors and Solid Tumors With YAP1/TAZ Fusion Genes;   NF2 Deficiency;   YAP1 or TAZ Gene Fusions Intervention:   Drug: IK-930 Sponsor:   Ikena Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2022 Category: Research Source Type: clinical trials

Deep Learning Magnetic Resonance Imaging Radiomics for Diagnostic Value of Hepatic Tumors in Infants
Conditions:   Hepatoblastoma;   Hepatic Hemangioendothelioma Intervention:   Diagnostic Test: Radiomic Algorithm Sponsor:   West China Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials